Transcriptomics

Dataset Information

0

Elevated systemic phenylalanine disrupts glutamate-dependent STING signaling in neutrophils and impairs cancer immunotherapy


ABSTRACT: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet acquired immune resistance remains a major barrier to durable response. Here, we identify a previously unrecognized immunometabolic axis in which elevated systemic phenylalanine (Phe) - driven by dietary intake or ICI-induced hepatic dysfunction - promotes immune evasion. Mechanistically, ICI-induced IL-6 and IFN-γ trigger proteasomal degradation of phenylalanine hydroxylase (PAH) via a TOPK-HECTD1 pathway in hepatocytes, leading to increased circulating Phe. Excess Phe suppresses antitumor immunity by impairing STING activation in tumor-associated neutrophils (TANs), through antagonism of glutamate-GRIK1-CaMKIV signaling. We uncover a key STING phosphorylation site (S324/326) essential for ER-to-Golgi trafficking and type I interferon responses, which is disrupted by Phe. These effects are independent of cGAS-cGAMP and define a glutamate-sensing checkpoint in neutrophil immunity. Therapeutically, restoring PAH function using liver-targeted synthetic RNA mimetics of HULC - a noncoding RNA shown to allosterically enhance PAH enzymatic activity - or activating GRIK1 with SYM2081 reprograms the tumor microenvironment, enhances CD8⁺ T cell function, and overcomes ICI resistance. This work reveals hepatic metabolic reprogramming as a central mechanism of immune escape and highlights new therapeutic opportunities to boost immunotherapy efficacy.

ORGANISM(S): Mus musculus

PROVIDER: GSE303168 | GEO | 2025/07/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-04-17 | E-GEOD-37328 | biostudies-arrayexpress
| PRJNA1294284 | ENA
2023-03-05 | GSE200783 | GEO
2023-03-05 | GSE223662 | GEO
2015-12-18 | GSE74114 | GEO
2022-05-04 | GSE201722 | GEO
2021-12-29 | GSE174757 | GEO
2015-12-18 | E-GEOD-74114 | biostudies-arrayexpress
2025-01-18 | PXD054049 | Pride
2024-10-17 | PXD054202 | Pride